LONDON, March 3, 2016 /PRNewswire/ --
Delegates discuss the global paradigm shift toward a value-based model of healthcare
The Economist Events' Value-based Healthcare in Europe 2016 summit, held at the Institute of Directors in London on Tuesday, was host to some of the most influential leaders in the European healthcare sector. Discussions at the summit focused on how global health systems need to adapt to the unprecedented rate of medical and technological innovation revolutionising the industry and the potential advantages and practical difficulties of implementing a value-based model of healthcare across Europe.
The summit was attended by over 150 people including a mix of government representatives, industry leaders, stakeholders and high-level national and international media.
Muir Gray, Director, Better Value Healthcare, Former Chief Knowledge Officer, National Health Service, Professor of Knowledge Management, University of Oxford, commented: "We are leaving the era of quality and safety and entering the era of value. Low quality is of course always low value but high quality is not necessarily high value. We see three big problems in every country, unwarranted variation which reveals underuse of effective care and overuse of low value care, which always wastes resources and sometimes does harm".
Richard Bergström, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA) commented: "The value-based healthcare model, where the health outcomes of treatments are assessed relative to costs, is rapidly gaining traction all around Europe in the search to match the greater demand for healthcare with ensuring a high quality of healthcare services, managing innovation and financial sustainability. The summit provided some very interesting international insights into how this paradigm shift impacts our healthcare systems".
Speakers provided a diverse range of views on how to create a more sustainable framework for payers and improved care for citizens by implementing a value-based healthcare model that is rapidly gaining traction across the continent, as the desired path forward in improving health systems.
Key speakers at the Value-based Healthcare in Europe summit included:
- Josep Maria Argimon, Director, The Agency for Healthcare Quality and Evaluation (AQuAS)
- Richard Bergström, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
- Jens Deerberg-Wittram, Executive Director, The Boston Consulting Group
- Harald Enzmann , Head of Licensing Division Two, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
- George Freeman MP, Minister for Life Sciences, Department of Health and Department for Business, Innovation and Skills, UK
- Muir Gray, Director, Better Value Healthcare, Former Chief Knowledge Officer, National Health Service, Professor of Knowledge Management, University of Oxford
- Bengt Jönsson, Professor of Health Economics, Stockholm School of Economics
- Stefan Kapferer, Deputy Secretary-General, Organisation for Economic Co-operation and Development (OECD)
- Finn Børlum Kristensen, Secretariat Director, European Network for HTA (EUnetHTA)
- Beatrice Lorenzin, Minister of Health, Italy
- João Cristovão Martins , Director, Autoridade Nacional do Medicamento e Produtos de Saúde (INFARMED)
- John Milligan, President and Chief Operating Officer, Gilead Sciences
- Luca Pani, Director General, L'Agenzia Italiana del Farmaco (AIFA)
- Brieuc Van Damme, Deputy Head of Cabinet, Ministry of Social Affairs and Public Health, Belgium
Follow the VBH in Europe summit via @EconomistEvents #EconVBH on Twitter to get the latest updates.
Want more from The Economist Events?
Join us on Twitter: @EconomistEvents
About The Economist Events
The Economist Events is the leading provider of international forums for senior executives seeking new insights into strategic issues. These meetings include industry conferences, management events and government roundtables held around the world. As part of The Economist Group, The Economist Events is a highly respected brand with a 162-year history and an unrivalled reputation for excellence and independence. Each meeting organised by The Economist Events delivers objective and informed analysis. Our meetings provide unusually high-level forums where senior executives can gain insights, exchange views and compare strategies.
Attend our events: www.economist.com/events
Event sponsor: Gilead
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions.
Supporting PR agency: Consilium Strategic Communications Consilium is an international advisory firm specialising in healthcare strategic communications. From offices in London and the US, Consilium's highly-skilled team provides long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes, investor relations and stakeholder challenges.
For general queries or further information about the event please call +44(0)207-576-8118 or e-mail firstname.lastname@example.org.
SOURCE Consilium Strategic Communications